UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

Videos
Event

Playback speed

10 seconds

Best of ASH on SCT in Leukemias: Who Should Be Referred Early for ASCT? Does MRD Status Matter? What Is the Role of HMA + Ven? Who Should Consider Maintenance Therapy w/o Consolidative alloSCT?

By UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts FEATURING Satyajit Kosuri

82 views

March 8, 2021

Comments 0

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Videos

ASH Updates on R/R MM: How to Choose Amongst Available Regimens at 1…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

B. Derman

265 views

ASH Updates on Frontline MM: What Is the Optimal Induction Regimen? …

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

B. Derman

324 views

35 y/o Male With Newly Diagnosed ALL: What Findings Are Traditionall…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

38 views

63 y/o Male With MCL: What Initial Therapy to Choose? What Would Be …

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

237 views

Newly Diagnosed MM Case Discussion: Classifying Patient Risk, and Ap…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

210 views

Expert Analysis of a Primary Myelofibrosis Case: What Tests Could Be…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

107 views

ASH Updates on Non-Malignant Hematology: Mycophenolate for ITP, CTX0…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

M. Thirman

21 views

ASH Practice Changing Updates in AML: Maintenance Oral Aza, Lower In…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

C. DiNardo

131 views

ASH Advances in Cellular Therapy: Tisa-Cel in R/R B-ALL, Blinatumoma…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Jakubowiak

36 views

ASH Highlights on High-Risk MDS in HMA Era: Oral HMAs, BCL2 Inhibiti…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

O. Odenike

27 views

Best of ASH on SCT in Leukemias: Who Should Be Referred Early for AS…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

S. Kosuri

82 views

ASH Update on SCT for Myeloid and Lymphoid Leukemias: Apamistamab as…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

S. Kosuri

61 views

ASH Updates on SoC in Lymphomas: How Beneficial Are Newly Approved B…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

161 views

ASH Updates on cHL: 2L Pembro + GVD, Brentuximab Vedotin & Checkpoin…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

121 views

ASH Updates on SoC in R/R MCL: How Active Are Novel BTKi & CAR-T The…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

29 views